Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.003.00%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.64M | 1.18M | 983.50K | 983.50K | 1.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.64M | 1.18M | 983.50K | 983.50K | 1.36M |
| Cost of Revenue | 872.90K | 679.00K | 397.70K | 397.70K | 420.40K |
| Gross Profit | 1.77M | 501.60K | 585.80K | 585.80K | 943.90K |
| SG&A Expenses | 1.42M | 846.20K | 741.10K | 741.10K | 757.10K |
| Depreciation & Amortization | 97.70K | 76.10K | 54.80K | 54.80K | 51.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.39M | 1.60M | 1.19M | 1.19M | 1.23M |
| Operating Income | 251.30K | -420.80K | -210.10K | -210.10K | 135.00K |
| Income Before Tax | -876.30K | -4.35M | -1.31M | -1.31M | -760.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -876.30K | -4.35M | -1.31M | -1.31M | -760.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -876.30K | -4.35M | -1.31M | -1.31M | -760.00K |
| EBIT | 251.30K | -420.80K | -210.10K | -210.10K | 135.00K |
| EBITDA | 349.00K | -344.70K | -155.30K | -155.30K | 186.80K |
| EPS Basic | -0.07 | -0.35 | -0.10 | -0.10 | -0.06 |
| Normalized Basic EPS | -0.04 | -0.20 | -0.07 | -0.07 | -0.04 |
| EPS Diluted | -0.07 | -0.35 | -0.10 | -0.10 | -0.06 |
| Normalized Diluted EPS | -0.04 | -0.20 | -0.07 | -0.07 | -0.04 |
| Average Basic Shares Outstanding | 13.14M | 12.54M | 12.54M | 12.54M | 12.54M |
| Average Diluted Shares Outstanding | 13.14M | 12.54M | 12.54M | 12.54M | 12.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |